Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: A meta-analysis of the liraglutide clinical trial programme

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: A meta-analysis of the liraglutide clinical trial programme

Veure altres versions (1)

Aim: Effective type 2 diabetes management requires a multifactorial approach extending beyond glycaemic control. Clinical practice guidelines suggest targets for HbA1c, blood pressure and lipids, and emphasize weight reduction and avoiding hypoglycaemia. The phase 3 clinical trial programme for lira...

Descripció completa

Dades bibliogràfiques
Autors principals:	Zinman, B, Schmidt, W, Moses, A, Lund, N, Gough, S
Format:	Journal article
Idioma:	English
Publicat:	2012

Ítems similars

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme.
per: Zinman, B, et al.
Publicat: (2012)

Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss
per: Schmidt, W, et al.
Publicat: (2009)

Liraglutide Is Associated with Reduced Rates of Hypoglycemic Events Versus Glimepiride When Achieving Target HbA(1c)
per: Gough, S, et al.
Publicat: (2010)

Reductions in HbA(1c) and the incidence of hypoglycaemic episodes are not affected by renal impairment in patients with type 2 diabetes treated with liraglutide
per: Gough, S, et al.
Publicat: (2011)

Continuation of Liraglutide during Fasting is not Associated with Hypoglycaemia
per: Rosalie Koot, et al.
Publicat: (2017-10-01)

Liraglutide: from clinical trials to clinical practice.
per: Gough, S
Publicat: (2012)

Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997–2017: Time trends in incidence and HbA1c and glucose‐lowering drug use before and after hypoglycaemia
per: Mads Bisgaard Bengtsen, et al.
Publicat: (2021-07-01)

Achieving glycaemic control and weight loss with incretin-based therapies: a comparison of liraglutide, exenatide, and sitagliptin
per: Zinman, B, et al.
Publicat: (2011)

Liraglutide More Effectively Achieves a Composite Endpoint for A1C, SBP and Weight Change Than Other Diabetes Therapies
per: Zinman, B, et al.
Publicat: (2009)

Diagnosis of diabetes: HbA1c versus WHO criteria
per: Manley, S, et al.
Publicat: (2010)

Fructosamine and HbA1c
per: Kurumbian Chandran, et al.
Publicat: (2024-02-01)

The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.
per: Manuel Jonas Richter, et al.
Publicat: (2016-01-01)

Hypoglycaemia in clinical diabetes /
per: Frier, Brian M, et al.
Publicat: (2007)

The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables.
per: Marcus Lind, et al.
Publicat: (2009-01-01)

HbA1C and diabetes – an overview
per: S Pathmanathan, et al.
Publicat: (2014-01-01)

How should HbA(1c) be incorporated into the diagnostic pathway for diabetes mellitus?
per: Manley, SE, et al.
Publicat: (2010)

High-performance liquid chromatography local reference ranges of hemoglobin fractions (HbA, HbA2, and HbF) in detection of hemoglobinopathies in western Kenya
per: Benard Mutua, et al.
Publicat: (2022-12-01)

Could HbA(1c) have a role in the diagnosis of type 2 diabetes?
per: Manley, SE, et al.
Publicat: (2007)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
per: Xiaojing Feng, et al.
Publicat: (2021-05-01)

Cyclical variation in HbA1c values during the year: clinical and research implications.
per: Hill, N, et al.
Publicat: (2013)

Assessing the Clinical Utility of Point of Care HbA1c in the Ophthalmology Outpatient Setting
per: Mamtora S, et al.
Publicat: (2021-01-01)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements.
per: Nasir, N.M., et al.
Publicat: (2010)

Use of HbA1c in the diagnosis of diabetes.
per: Farmer, A
Publicat: (2012)

Effects of thyroid status on HbA1c
per: Sivaranjani Ambalavanan, et al.
Publicat: (2024-11-01)

Drugs affecting HbA1c levels
per: Ranjit Unnikrishnan, et al.
Publicat: (2012-01-01)

Current Status of HbA1c Biosensors
per: Hua Lin, et al.
Publicat: (2017-08-01)

Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
per: Susanne Amsberg, et al.
Publicat: (2023-12-01)

The Influence of HbA1c and Gestational Weight Gain on Pregnancy Outcomes in Pregnant Women With Gestational Diabetes Mellitus
per: Qiuhong Zhang, et al.
Publicat: (2022-05-01)

Haemoglobin types and variant interference with HbA1c and its association with uncontrolled HbA1c in type 2 diabetes mellitus
per: Joseph Malaba, et al.
Publicat: (2024-11-01)

Symposium 3: HbA1c: Are HbA1c determinations reliable enough today in Argentina to adopt them as diagnostic criteria?
per: Carla Lucarelli
Publicat: (2022-09-01)

Significantly High HbA1c in Diabetic Patient with Hb J: Case Report
per: Wan Nor Fazila Hafizan Wan Nik, et al.
Publicat: (2022-07-01)

Low HbA2 Level in β-Thalassemia Trait
per: Şinasi Özsoylu
Publicat: (2013-03-01)

Engineering of the endogenous HBD promoter increases HbA2
per: Mandy Y Boontanrart, et al.
Publicat: (2023-06-01)

Symposium 5: HbA1c: Infection management
per: Marcia Querci
Publicat: (2022-09-01)

HbA2 measurements in β-thalassemia and in other conditions
per: Giovanni Ivaldi, et al.
Publicat: (2014-09-01)

The clinical value of HbA1c in combination with FPG in the early screening of the elderly with type 2 diabetes
per: Liu Lihua, et al.
Publicat: (2017-01-01)

HbA1c in patients with glioblastomas - a preliminary study
per: D. Orešković, et al.
Publicat: (2022-01-01)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
per: Bao Sun, et al.
Publicat: (2022-11-01)

Unexpected Detection of Abnormal Hemoglobin Variants During Routine HbA1c Analysis by HPLC Technique: Challenges and Opportunities in HbA1c Testing
per: Neelam Narsingrao Sreedevi, et al.
Publicat: (2021-06-01)

Algorithm combining HbA(1c) and fasting plasma glucose for screening subjects for OGTT: Authors' response
per: Manley, SE, et al.
Publicat: (2009)